Related Experiment Video

Updated: May 22, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement

M A Calderon1, R Gerth van Wijk, I Eichler

  • 1Department of Allergy and Respiratory Medicine, Royal Brompton Hospital, Imperial College, London, UK. m.calderon@imperial.ac.uk

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|May 19, 2012
PubMed

Insights

This consensus report addresses allergen-specific immunotherapy (ASIT) in children, identifying unmet needs and providing recommendations for researchers, organizations, and regulators to improve pediatric allergy care.

Area of Science:

  • Pediatric Allergology
  • Immunotherapy
  • Regulatory Science

Background:

  • Expert consensus on allergen-specific immunotherapy (ASIT) in childhood.
  • Addresses clinical, scientific, regulatory, and ethical dimensions of pediatric ASIT.
  • Identifies unmet needs in the field of pediatric allergy treatment.

Framework:

  • Multidisciplinary working group including clinical experts, ethicists, and European Medicines Agency (EMA) representatives.
  • Focuses on bridging diverse perspectives to advance pediatric ASIT.
  • Establishes a collaborative framework for future research and clinical practice.

Implementation:

  • Recommendations targeted at researchers, scientific and patient organizations, regulators, and ethical committees.
  • Aims to fill identified knowledge and practice gaps in pediatric immunotherapy.
  • Promotes collaborative efforts to enhance the benefit of ASIT for children.

Implications:

  • Enhances understanding and application of ASIT in pediatric populations.
  • Facilitates improved regulatory pathways and ethical considerations for pediatric treatments.
  • Strengthens cooperation within the allergy community for better patient outcomes.

More Related Videos

Basophil Activation Test for Allergy Diagnosis07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cross-reactivity00:42

Cross-reactivity

Overview